Pharma

Your Article Summary

See Latest Articles

Mylan Receives Final FDA Approvals for Generic Versions of Anti-Rejection Medication CellCept
Mylan, 05/08/09

Mylan Inc. announced that its subsidiary Mylan Pharmaceuticals Inc. received final approvals from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for Mycophenolate Mofetil Tablets, 500 mg, and Mycophenolate Mofetil Capsules, 250 mg.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09

 See all of Drug/Product Approvals